CD19 and systemic lupus erythematosus: Their data indicate that CD19(hi) SLE patients exhibit a distinct autoantibody profile characterized by high levels of antibodies to snRNPs and low levels of anti-glomerular autoantibodies [41], suggesting that B cells play a crucial role in the determination of the autoantibody specificities.